Myelin Protein Zero-Like 2 (MPZL2) (N-Term) Peptide
MPZL2
Reactivité: Humain
Hôte: Synthetic
BP, WB
N° du produit ABIN980223
Aperçu rapide pour Myelin Protein Zero-Like 2 (MPZL2) (N-Term) Peptide (ABIN980223)
Antigène
MPZL2
(Myelin Protein Zero-Like 2 (MPZL2))
Origine
Humain
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB)
Protein Region
N-Term
Attributs du produit
This is a synthetic peptide designed for use in combination with anti-MPZL2 antibody (Catalog #: ARP46654_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
Each Investigator should determine their own optimal working dilution for specific applications.
Restrictions
For Research Use only
Format
Lyophilized
Reconstitution
Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
Concentration
1 mg/mL
Buffer
Final peptide concentration is 1 mg/mL in PBS.
Conseil sur la manipulation
Avoid repeated freeze-thaw cycles.
Stock
-20 °C
Stockage commentaire
For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
Antigène
MPZL2
(Myelin Protein Zero-Like 2 (MPZL2))
Sujet
Epithelial V-like antigen (EVA) is expressed in thymus epithelium and strongly downregulated by thymocyte developmental progression. This gene is expressed in the thymus and in several epithelial structures early in embryogenesis. It is highly homologous